Warby SC et al (2011) HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet 19(5):561–566

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li HL, Zhang YB, Wu ZY (2017) Development of research on Huntington disease in China. Neurosci Bull 33(3):312–316

Article  PubMed  Google Scholar 

Podvin S et al (2019) Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration. J Neurol 266(3):551–564

Article  CAS  PubMed  Google Scholar 

Li HL et al (2019) Clinical and genetic profiles in Chinese patients with Huntington’s disease: a ten-year multicenter study in China. Aging Dis 10(5):1003–1011

Article  PubMed  PubMed Central  Google Scholar 

Langbehn DR et al (2004) A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clin Genet 65(4):267–277

Article  CAS  PubMed  Google Scholar 

Warby SC et al (2009) CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 84(3):351–366

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becanovic K et al (2015) A SNP in the HTT promoter alters NF-kappaB binding and is a bidirectional genetic modifier of Huntington disease. Nat Neurosci 18(6):807–816

Article  CAS  PubMed  Google Scholar 

Kim KH et al (2020) Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects. Am J Hum Genet 107(1):96–110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flower M et al (2019) MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1. Brain 142(7):1876–1886

Ciosi M et al (2019) A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. EBioMedicine 48:568–580

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li XY et al (2020) Haplotype analysis encompassing HTT gene in Chinese patients with Huntington’s disease. Eur J Neurol 27(2):273–279

Article  PubMed  Google Scholar 

Cheng HR et al (2020) Correlation between CCG polymorphisms and CAG repeats during germline transmission in chinese patients with Huntington’s disease. Neurosci Bull 36(7):811–814

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li XY et al (2019) Effect of apolipoprotein E genotypes on Huntington’s disease phenotypes in a Han Chinese population. Neurosci Bull 35(4):756–762

Article  CAS  PubMed  PubMed Central  Google Scholar 

Genetic Modifiers of Huntington’s Disease Consortium (2019) CAG repeat not polyglutamine length determines timing of Huntington’s disease onset. Cell 178(4):887–900 e14

Wright GEB et al (2019) Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease. Am J Hum Genet 104(6):1116–1126

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wright GEB et al (2020) Interrupting sequence variants and age of onset in Huntington’s disease: clinical implications and emerging therapies. Lancet Neurol 19(11):930–939

Article  CAS  PubMed  Google Scholar 

Findlay Black H et al (2020) Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range. Genet Med 22(12):2108–2113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Houge G et al (2013) De novo Huntington disease caused by 26–44 CAG repeat expansion on a low-risk haplotype. Neurology 81(12):1099–1100

Article  PubMed  PubMed Central  Google Scholar 

Li XY et al (2022) The Chinese version of UHDRS in Huntington’s disease: reliability and validity assessment. J Huntingtons Dis 11(4):407–413

Article  CAS  PubMed  Google Scholar 

Ross CA et al (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10(4):204–216

Article  CAS  PubMed  Google Scholar 

Dong Y et al (2013) Chinese patients with Huntington’s disease initially presenting with spinocerebellar ataxia. Clin Genet 83(4):380–383

Article  CAS  PubMed  Google Scholar 

Green MR, Sambrook J (2021) Cloning polymerase chain reaction (PCR) products: TA cloning. Cold Spring Harb Protoc (6)

Lee JM et al (2012) CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78(10):690–695

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe M et al (2000) De novo expansion of a CAG repeat in a Japanese patient with sporadic Huntington’s disease. J Neurol Sci 178(2):159–162

Article  CAS  PubMed  Google Scholar 

Semaka A, Collins JA, Hayden MR (2010) Unstable familial transmissions of Huntington disease alleles with 27–35 CAG repeats (intermediate alleles). Am J Med Genet B Neuropsychiatr Genet 153B(1):314–320

CAS  PubMed  Google Scholar 

Semaka A et al (2013) CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. J Med Genet 50(10):696–703

Article  CAS  PubMed  Google Scholar 

Zhou MY, Gomez-Sanchez CE (2000) Universal TA cloning. Curr Issues Mol Biol 2(1):1–7

CAS  PubMed  Google Scholar